Liu Guanglin, graduated from the executive vice president of Handan liver disease hospital of Hebei Medical College, master of hospital management (MBA) of Renmin University of China, executive director of Handan Pharmaceutical Association and member of Handan drug monitoring and consulting expert database. The main member of the research group of dredging chemical fiber therapy, who is good at using traditional Chinese medicine to prevent and treat liver diseases and has been engaged in the treatment of liver diseases for nearly 30 years, is the main research member of Anluo chemical fiber pill, a national new drug for liver treatment.